Figure 5From: Small- bowel mucosal changes and antibody responses after low- and moderate-dose gluten challenge in celiac disease Changes in antibody levels. Transglutaminase 2 (TG2) antibody levels at baseline, at 4 and 8 weeks, and at the end of the study. Closed squares indicate moderate daily gluten dose 3-5 g and open squares low gluten doses (1-3 g per day).Back to article page